TY - JOUR
T1 - Multifunctional biomolecule nanostructures for cancer therapy
AU - Wang, Jing
AU - Li, Yiye
AU - Nie, Guangjun
N1 - Funding Information:
We sincerely acknowledge all researchers and their work in our field that we were unable to cite because of space limitations. This work was supported by the National Basic Research Plan of China (2018YFA0208900), the National Key R&D Program of China (2018YFE0205300), the Strategic Priority Research Program of Chinese Academy of Sciences (XDB36000000), the Key Research Program of Frontier Sciences CAS (ZDBS-LY-SLH039) and the K.C. Wong Education Foundation (GJTD-2018-03).
Publisher Copyright:
© 2021, Springer Nature Limited.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/9
Y1 - 2021/9
N2 - Biomolecule-based nanostructures are inherently multifunctional and harbour diverse biological activities, which can be explored for cancer nanomedicine. The supramolecular properties of biomolecules can be precisely programmed for the design of smart drug delivery vehicles, enabling efficient transport in vivo, targeted drug delivery and combinatorial therapy within a single design. In this Review, we discuss biomolecule-based nanostructures, including polysaccharides, nucleic acids, peptides and proteins, and highlight their enormous design space for multifunctional nanomedicines. We identify key challenges in cancer nanomedicine that can be addressed by biomolecule-based nanostructures and survey the distinct biological activities, programmability and in vivo behaviour of biomolecule-based nanostructures. Finally, we discuss challenges in the rational design, characterization and fabrication of biomolecule-based nanostructures, and identify obstacles that need to be overcome to enable clinical translation.
AB - Biomolecule-based nanostructures are inherently multifunctional and harbour diverse biological activities, which can be explored for cancer nanomedicine. The supramolecular properties of biomolecules can be precisely programmed for the design of smart drug delivery vehicles, enabling efficient transport in vivo, targeted drug delivery and combinatorial therapy within a single design. In this Review, we discuss biomolecule-based nanostructures, including polysaccharides, nucleic acids, peptides and proteins, and highlight their enormous design space for multifunctional nanomedicines. We identify key challenges in cancer nanomedicine that can be addressed by biomolecule-based nanostructures and survey the distinct biological activities, programmability and in vivo behaviour of biomolecule-based nanostructures. Finally, we discuss challenges in the rational design, characterization and fabrication of biomolecule-based nanostructures, and identify obstacles that need to be overcome to enable clinical translation.
UR - http://www.scopus.com/inward/record.url?scp=85106231145&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106231145&partnerID=8YFLogxK
U2 - 10.1038/s41578-021-00315-x
DO - 10.1038/s41578-021-00315-x
M3 - Review article
AN - SCOPUS:85106231145
VL - 6
SP - 766
EP - 783
JO - Nature Reviews Materials
JF - Nature Reviews Materials
SN - 2058-8437
IS - 9
ER -